CARDON BIO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CARDON BIO
Largest movements
- Receivables within one year +€205,963
up €205,963 (+174%), from €118,475 to €324,438
of which Other amounts receivable: +€155,963
- Trade debts +€186,248
up €186,248 (+557%), from €33,425 to €219,673
- Profit (loss) carried forward +€11,308
up €11,308 (+127%), from €8,890 to €20,197
- Reserves +€6,200
new in 2025: €6,200
- Other operating charges -€49,741
down €49,741 (-99.2%), from €50,150 to €409
- Gross operating margin -€44,771
down €44,771 (-63.6%), from €70,397 to €25,626
- Taxes +€3,395
up €3,395 (+114%), from €2,979 to €6,373
- Financial charges +€893
up €893 (+201%), from €445 to €1,338
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €118,869 | €324,561 | +€205,691 | +173% |
| Current assets | 29/58 | €118,869 | €324,561 | +€205,691 | +173% |
| Stocks and contracts in progress | 3 | €0 | - | = | |
| Stocks | 30/36 | €0 | - | = | |
| Amounts receivable within one year | 40/41 | €118,475 | €324,438 | +€205,963 | +174% |
| Trade receivables | 40 | €0 | €50,000 | +€50,000 | |
| Other amounts receivable | 41 | €118,475 | €274,438 | +€155,963 | +132% |
| Cash at bank and in hand | 54/58 | €394 | €122 | -€272 | -69.0% |
| Total equity and liabilities | 10/49 | €118,869 | €324,561 | +€205,691 | +173% |
| Equity | 10/15 | €70,890 | €88,397 | +€17,508 | +24.7% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | - | €6,200 | +€6,200 | |
| Non-distributable reserves | 130/1 | - | €6,200 | +€6,200 | |
| Legal reserve | 130 | - | €6,200 | +€6,200 | |
| Profit (loss) carried forward | 14 | €8,890 | €20,197 | +€11,308 | +127% |
| Amounts payable | 17/49 | €47,980 | €236,163 | +€188,184 | +392% |
| Amounts payable within one year | 42/48 | €47,980 | €236,163 | +€188,184 | +392% |
| Trade debts | 44 | €33,425 | €219,673 | +€186,248 | +557% |
| Suppliers | 440/4 | €33,425 | €219,673 | +€186,248 | +557% |
| Taxes, remuneration and social security | 45 | €14,555 | €16,490 | +€1,935 | +13.3% |
| Taxes | 450/3 | €14,555 | €16,490 | +€1,935 | +13.3% |
| Other operating charges | 640/8 | €50,150 | €409 | -€49,741 | -99.2% |
| Gross operating margin | 9900 | €70,397 | €25,626 | -€44,771 | -63.6% |
| Operating profit (loss) | 9901 | €20,247 | €25,217 | +€4,970 | +24.5% |
| Financial income | 75/76B | - | €1 | +€1 | |
| Recurring financial income | 75 | - | €1 | +€1 | |
| Financial charges | 65/66B | €445 | €1,338 | +€893 | +201% |
| Recurring financial charges | 65 | €445 | €1,338 | +€893 | +201% |
| Profit (loss) for the period before taxes | 9903 | €19,802 | €23,881 | +€4,079 | +20.6% |
| Income taxes | 67/77 | €2,979 | €6,373 | +€3,395 | +114% |
| Profit (loss) for the period | 9904 | €16,823 | €17,508 | +€684 | +4.1% |
| Profit (loss) for the period to be appropriated | 9905 | €16,823 | €17,508 | +€684 | +4.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.